MoonLake Immunotherapeutics ($MLTX)
Filing Information
| Accession Number | 0001213900-26-070259 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 18, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
17,876
Total Value
$351,576.16
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Class A ordinary shares, par value $0.0001 per share | โ | Jun 17, 2026 | Sale | 15,082 | $19.68 | $296,813.76 | 1,157,349 | Direct | โ | View Details | |
Chief Financial Officer | Class A ordinary shares, par value $0.0001 per share | โ | Jun 18, 2026 | Sale | 2,794 | $19.60 | $54,762.40 | 1,154,555 | Direct | โ | View Details |